Know Cancer

or
forgot password

A Pilot Study to Evaluate the Quality of Life of Long Term Survivors of Adult Acute Lymphoblastic Leukemia


N/A
18 Years
N/A
Not Enrolling
Both
Acute Lymphoblastic Leukemia

Thank you

Trial Information

A Pilot Study to Evaluate the Quality of Life of Long Term Survivors of Adult Acute Lymphoblastic Leukemia


Inclusion Criteria:



- previously diagnosed with adult ALL or T-lymphoblastic lymphoma

- Age >/= 18

- Have completed the two-year modified DFCI protocol at least three months earlier and
are in continuous complete remission

- Understand English and are able to fill out questionnaires

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

To evaluate the quality of life of the long-term survivors of adult acute lymphoblastic leukemia treated uniformly with the modified Dana Farber Cancer Institute ALL protocol (91-01)

Outcome Time Frame:

9 months

Safety Issue:

Yes

Principal Investigator

Joseph M Brandwein, MD, FRCPC

Investigator Role:

Principal Investigator

Investigator Affiliation:

Princess Margaret Hospital, Canada

Authority:

Canada: Ethics Review Committee

Study ID:

09-0619-CE

NCT ID:

NCT01148927

Start Date:

November 2009

Completion Date:

October 2012

Related Keywords:

  • Acute Lymphoblastic Leukemia
  • Leukemia
  • Leukemia, Lymphoid
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma

Name

Location